These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8045741)

  • 21. The relation between production of cytotoxin and clinical features in shigellosis.
    Prado D; Cleary TG; Pickering LK; Ericsson CD; Bartlett AV; DuPont HL; Johnson PC
    J Infect Dis; 1986 Jul; 154(1):149-55. PubMed ID: 3519788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenesis of Shigella diarrhea: XVII. A mammalian cell membrane glycolipid, Gb3, is required but not sufficient to confer sensitivity to Shiga toxin.
    Jacewicz MS; Mobassaleh M; Gross SK; Balasubramanian KA; Daniel PF; Raghavan S; McCluer RH; Keusch GT
    J Infect Dis; 1994 Mar; 169(3):538-46. PubMed ID: 8158025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of interferon and tumour necrosis factor on development of intracellular bacterial infections.
    Degré M; Bukholm G
    Acta Microbiol Hung; 1988; 35(4):405-10. PubMed ID: 2469282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Shigella toxin(s): description and role in diarrhea and dysentery.
    Keusch GT; Donohue-Rolfe A; Jacewicz M
    Pharmacol Ther; 1981; 15(3):403-38. PubMed ID: 7048347
    [No Abstract]   [Full Text] [Related]  

  • 25. The systemic administration of lethal toxin achieves a growth delay of human melanoma and neuroblastoma xenografts: assessment of receptor contribution.
    Rouleau C; Menon K; Boutin P; Guyre C; Yoshida H; Kataoka S; Perricone M; Shankara S; Frankel AE; Duesbery NS; Vande Woude G; Biemann HP; Teicher BA
    Int J Oncol; 2008 Apr; 32(4):739-48. PubMed ID: 18360701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative evaluation of apoptosis induced by Shiga toxin 1 and/or lipopolysaccharides in human monocytic and macrophage-like cells.
    Harrison LM; Cherla RP; van den Hoogen C; van Haaften WC; Lee SY; Tesh VL
    Microb Pathog; 2005; 38(2-3):63-76. PubMed ID: 15748808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The mechanism of action of Shiga toxin].
    Dubinina EN; Luk'ianov EV; Kozlov IuV; Baev AA
    Dokl Akad Nauk SSSR; 1988; 302(1):226-8. PubMed ID: 3229307
    [No Abstract]   [Full Text] [Related]  

  • 28. One step high yield affinity purification of shiga-like toxin II variants and quantitation using enzyme linked immunosorbent assays.
    Acheson DW; Jacewicz M; Kane AV; Donohue-Rolfe A; Keusch GT
    Microb Pathog; 1993 Jan; 14(1):57-66. PubMed ID: 8321118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uncoupling of S-phase and mitosis by recombinant cytotoxic necrotizing factor 2 (CNF2).
    Denko N; Langland R; Barton M; Lieberman MA
    Exp Cell Res; 1997 Jul; 234(1):132-8. PubMed ID: 9223378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of a Shiga toxin-encoding temperate bacteriophage of Shigella sonnei.
    Strauch E; Lurz R; Beutin L
    Infect Immun; 2001 Dec; 69(12):7588-95. PubMed ID: 11705937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenesis of Shigella diarrhea. XVI. Selective targetting of Shiga toxin to villus cells of rabbit jejunum explains the effect of the toxin on intestinal electrolyte transport.
    Kandel G; Donohue-Rolfe A; Donowitz M; Keusch GT
    J Clin Invest; 1989 Nov; 84(5):1509-17. PubMed ID: 2681267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytoprotective effect of curcumin in human proximal tubule epithelial cells exposed to shiga toxin.
    Sood A; Mathew R; Trachtman H
    Biochem Biophys Res Commun; 2001 Apr; 283(1):36-41. PubMed ID: 11322764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular genetics of virulence in Shigella.
    Binns MM
    Microbiol Sci; 1985 Sep; 2(9):275-8. PubMed ID: 2484669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytopathic effects of shigellae on Vero & HeLa cells.
    Ramachandran VG; Varghese A; Agarwal DS
    Indian J Med Res; 1983 Aug; 78():161-9. PubMed ID: 6654406
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluation of multiplex PCRs for diagnosis of infection with diarrheagenic Escherichia coli and Shigella spp.
    Aranda KR; Fagundes-Neto U; Scaletsky IC
    J Clin Microbiol; 2004 Dec; 42(12):5849-53. PubMed ID: 15583323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition by toxin B of inositol phosphate formation induced by G protein-coupled and tyrosine kinase receptors in N1E-115 neuroblastoma cells: involvement of Rho proteins.
    Zhang C; Schmidt M; von Eichei-Streiber C; Jakobs KH
    Mol Pharmacol; 1996 Oct; 50(4):864-9. PubMed ID: 8863831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenesis of shigella diarrhea: evidence for an N-linked glycoprotein shigella toxin receptor and receptor modulation by beta-galactosidase.
    Keusch GT; Jacewicz M; Donohue-Rolfe A
    J Infect Dis; 1986 Feb; 153(2):238-48. PubMed ID: 3003205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of Shiga toxin in the pathogenesis of bacillary dysentery, studied by using a Tox- mutant of Shigella dysenteriae 1.
    Fontaine A; Arondel J; Sansonetti PJ
    Infect Immun; 1988 Dec; 56(12):3099-109. PubMed ID: 3053452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic induction of apoptosis in neuroblastoma cells using a combination of cytostatic drugs with interferon-gamma and TRAIL.
    Johnsen JI; Pettersen I; Ponthan F; Sveinbjørnsson B; Flaegstad T; Kogner P
    Int J Oncol; 2004 Dec; 25(6):1849-57. PubMed ID: 15547726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Shiga toxin-associated hemolytic-uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1 beta, and tumor necrosis factor alpha on human vascular endothelial cells in vitro.
    Louise CB; Obrig TG
    Infect Immun; 1991 Nov; 59(11):4173-9. PubMed ID: 1937774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.